NCT00493987View on ClinicalTrials.gov

The Role of 5-alpha Reductase in Mediating Testosterone Actions

PHASE4CompletedINTERVENTIONAL
Enrollment

184

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

December 31, 2009

Study Completion Date

March 31, 2010

Conditions
Healthy
Interventions
DRUG

Testosterone Enanthate

testosterone ester

DRUG

Dutasteride

5 alpha-reductase inhibitor

Trial Locations (1)

02118

Boston University Medical Center, Boston

All Listed Sponsors
lead

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

NCT00493987 - The Role of 5-alpha Reductase in Mediating Testosterone Actions | Biotech Hunter | Biotech Hunter